News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).
Quest Diagnostics Inc. is offering services to large employers geared at getting their employees back to work safely, including testing for the novel coronavirus, analytics to monitor symptoms and hotspots, and services like temperature monitoring, the company announced Wednesday.
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
E-commerce companies Amazon Inc and eBay Inc have been instructed by the U.S. Environmental Protection Agency (EPA) to stop selling unproven or unsafe disinfectants, including products falsely marketed as killing COVID-19, on their platforms, Bloomberg reported on Thursday.
Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease.
On March 30, Raytheon Technologies CEO Greg Hayes made a promise to the nation. At the White House, he announced the company would deploy 3D printers and other technology to produce 10,000 medical face shields. That goal was reached in 23 days, and now Raytheon Technologies is aimed at more than doubling that production while the pandemic rages.
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created by Oxford University, inking a series of deals with non-government organizations and another manufacturer.
Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.